Rituximab in patients with refractory thrombotic thrombocytopenic purpura [2]

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 5, 2004, Pages 834-836

  Sallah, Sabah ^a,d   Husain, A ^a   Wan, J Y ^b   Nguyen, N P ^c  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c Department of Radiation Oncology   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; ENZYME ANTIBODY; LACTATE DEHYDROGENASE; PREDNISONE; RITUXIMAB; VINCRISTINE; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; ANTIBODY DETECTION; CHILL; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DRUG DOSE REGIMEN; DRUG RESPONSE; EXPERIENCE; FEVER; HEADACHE; HUMAN; HYPOTENSION; LETTER; NAUSEA; PLASMAPHERESIS; PRIORITY JOURNAL; RELAPSE; REMISSION; SPLENECTOMY; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADULT; ANTIBODIES, MONOCLONAL; HUMANS; MIDDLE AGED; PURPURA, THROMBOTIC THROMBOCYTOPENIC; REMISSION INDUCTION; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 13244290054     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2004.00678.x     Document Type: Letter

References (7)

1. Furlan M, Robles R, Galbusera M, Remuzzi A, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lammle B. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome. N Engl J Med 1998; 339: 1578-84.
2. Tsai H-M, Lian EC. Antibodies to von willibrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998; 339: 1585-94.
3. Wiestner A, Hearn J, Asch AS, Michelis AM, Zeller JA, Peerschke EIB, Weksler BB, Schechter AP. Rituximab in the treatment of acquired factor VIII inhibitors. Blood 2002; 100: 3426-8.
4. Stasi R, Pagano A, Stipa E, Amadori S. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. Blood 2001; 98: 952-7.
5. Chemnitz J, Draube A, Scheild C, Staib P, Schulz A, Diehl V, Sohngen D. Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximab. Am J Hem 2002; 71: 105-8.
6. Zheng X, Pallera AM, Goodnough LT, Sadler JE, Blinder ME. Remisison of chronic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab. Ann Int Med 2003; 38: 105-8.
7. Gutterman LA, Klostr B, Tsai H-M. Rituximab therapy for refractory thrombotic thrombocytopenic purpura. Blood Cells Mol Dis 2002; 28: 385-91.